Rare diseases
Investigational molecules
Locations
Back to France1 clinical trial in Luc-La-Primaube, France. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in FranceEssaisCliniques.fr(opens in a new tab)FranceThe busiest research cities in the country
What the registry says about research in the country
Innovative clinical research focusing on Type 2 diabetes patients without prior cardiovascular events, exploring preventive therapeutic approaches using colchicine and non-enteric coated aspirin.
This comprehensive study aims to enhance cardiovascular outcomes in high-risk diabetic patients through preventive medication strategies, potentially revolutionizing standard care protocols for diabetes management.
Groundbreaking research investigating the effectiveness of combining standard care with low-dose medications to prevent major cardiovascular events in patients with diabetes.
The study evaluates innovative approaches to reduce cardiovascular complications, focusing on preventive strategies before the onset of evident cardiovascular disease.
Investigation of dual-therapy approaches in managing cardiovascular risk, examining both individual and combined effects of established medications in new applications.
This research explores the potential benefits of combining different therapeutic agents to create more effective prevention strategies for high-risk diabetic patients.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
